Prostate Cancer Therapeutics - Global Market Outlook (2017-2023)

Prostate Cancer Therapeutics - Global Market Outlook (2017-2023)

  • Published: June 2017
  • ID: SMRC16542

According to Stratistics MRC, the Global Prostate Cancer Therapeutics market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market. However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.

Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.

Drugs Classes Covered:
• Chemotherapy
o Estramustine (Emcyt)
o Mitoxantrone (Novantrone)
o Jevtana
o Taxotere
• Targeted Therapy
o Xofigo
• Hormonal Therapy
o Anti-Androgens
o Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
o Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
• Immunotherapy
o Provenge

Distribution Channels Covered:
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Other Distribution Channels

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary   
    
2 Preface   

 2.1 Abstract  
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology  
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions 
    
3 Market Trend Analysis   
 3.1 Introduction  
 3.2 Drivers  
 3.3 Restraints  
 3.4 Opportunities  
 3.5 Threats  
 3.6 Emerging Markets  
 3.7 Futuristic Market Scenario  
    
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry  
    
5 Global Prostate Cancer Therapeutics Market, By Drugs Class   
 5.1 Introduction  
 5.2 Chemotherapy  
  5.2.1 Estramustine (Emcyt) 
  5.2.2 Mitoxantrone (Novantrone) 
  5.2.3 Jevtana 
  5.2.4 Taxotere 
 5.3 Targeted Therapy  
  5.3.1 Xofigo 
 5.4 Hormonal Therapy  
  5.4.1 Anti-Androgens 
   5.4.1.1 Casodex
   5.4.1.2 Xtandi
  5.4.2 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists 
   5.4.2.1 Zytiga
   5.4.2.2 Gonax
   5.4.2.3 Firmagon
  5.4.3 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs 
   5.4.3.1 Vantas
   5.4.3.2 Eligard
   5.4.3.3 Decapeptyl
   5.4.3.4 Zoladex
   5.4.3.5 Lupron
 5.5 Immunotherapy  
  5.5.1 Provenge 
    
6 Global Prostate Cancer Therapeutics Market, By Distribution Channel  
 
 6.1 Introduction  
 6.2 Hospital Pharmacy  
 6.3 Retail Pharmacy  
 6.4 Online Sales  
 6.5 Other Distribution Channels  
    
7 Global Prostate Cancer Therapeutics Market, By Geography   
 7.1 North America  
  7.1.1 US 
  7.1.2 Canada 
  7.1.3 Mexico 
 7.2 Europe  
  7.2.1 Germany 
  7.2.2 France 
  7.2.3 Italy 
  7.2.4 UK 
  7.2.5 Spain 
  7.2.6 Rest of Europe 
 7.3 Asia Pacific  
  7.3.1 Japan 
  7.3.2 China 
  7.3.3 India 
  7.3.4 Australia 
  7.3.5 New Zealand 
  7.3.6 Rest of Asia Pacific 
 7.4 Rest of the World  
  7.4.1 Middle East 
  7.4.2 Brazil 
  7.4.3 Argentina 
  7.4.4 South Africa 
  7.4.5 Egypt 
    
8 Key Developments   
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 8.2 Acquisitions & Mergers  
 8.3 New Product Launch  
 8.4 Expansions  
 8.5 Other Key Strategies  
    
9 Company Profiling   
 9.1 Tolmar Inc   
 9.2 Teva Pharmaceutical Industries Ltd   
 9.3 Takeda Pharmaceutical Co. Ltd   
 9.4 Sanofi-Aventis   
 9.5 Pfizer Inc   
 9.6 Johnson & Johnson   
 9.7 Ipsen   
 9.8 Ferring Pharmaceuticals  
 9.9 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc)  
 9.10 Dendreon Corporation   
 9.11 Bristol-Myers Squibb   
 9.12 Astrazeneca Plc   
 9.13 Astellas Pharma Inc   
 9.14 Active Biotech  
 9.15 Abbott Laboratories   


List of Tables    
1 Global Prostate Cancer Therapeutics Market Outlook, By Region (2015-2023) ($MN)   
2 Global Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)   
3 Global Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)   
4 Global Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)   
5 Global Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)   
6 Global Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)   
7 Global Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)   
8 Global Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)   
9 Global Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)   
10 Global Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)   
11 Global Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)   
12 Global Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)   
13 Global Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)   
14 Global Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)   
15 Global Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)   
16 Global Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)   
17 Global Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)   
18 Global Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)   
19 Global Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)   
20 Global Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)   
21 North America Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)   
22 North America Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)   
23 North America Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)   
24 North America Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)   
25 North America Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)   
26 North America Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)   
27 North America Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)   
28 North America Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)   
29 North America Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)   
30 North America Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)   
31 North America Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)   
32 North America Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)   
33 North America Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)   
34 North America Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)   
35 North America Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)   
36 North America Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)   
37 North America Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)   
38 North America Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)   
39 North America Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)   
40 North America Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)   
41 Europe Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)   
42 Europe Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)   
43 Europe Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)   
44 Europe Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)   
45 Europe Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)   
46 Europe Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)   
47 Europe Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)   
48 Europe Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)   
49 Europe Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)   
50 Europe Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)   
51 Europe Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)   
52 Europe Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)   
53 Europe Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)   
54 Europe Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)   
55 Europe Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)   
56 Europe Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)   
57 Europe Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)   
58 Europe Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)   
59 Europe Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)   
60 Europe Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)   
61 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)   
62 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)   
63 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)   
64 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)   
65 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)   
66 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)   
67 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)   
68 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)   
69 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)   
70 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)   
71 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)   
72 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)   
73 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)   
74 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)   
75 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)   
76 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)   
77 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)   
78 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)   
79 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)   
80 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)   
81 RoW Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)   
82 RoW Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)   
83 RoW Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)   
84 RoW Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)   
85 RoW Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)   
86 RoW Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)   
87 RoW Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)   
88 RoW Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)   
89 RoW Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)   
90 RoW Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)   
91 RoW Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)   
92 RoW Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)   
93 RoW Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)   
94 RoW Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)   
95 RoW Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)   
96 RoW Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)   
97 RoW Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)   
98 RoW Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)   
99 RoW Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)   
100 RoW Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)   

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials